Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer
Author:
- 3 October 2011
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 31 (22) , 2703-2714
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes.Keywords
This publication has 104 references indexed in Scilit:
- Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in HumansScience Translational Medicine, 2011
- New plays in the p53 theaterCurrent Opinion in Genetics & Development, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Δ40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCsGenes & Development, 2010
- MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cellsBiochemical Journal, 2010
- Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cellsMolecular and Cellular Endocrinology, 2010
- The LKB1–AMPK pathway: metabolism and growth control in tumour suppressionNature Reviews Cancer, 2009
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisThe Lancet, 2004
- Regulation of p53 in response to DNA damageOncogene, 1999
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998